Scala Biodesign
About
Scala Biodesign leverages a unique computational platform that integrates evolutionary analysis, atomistic protein design calculations, and artificial intelligence to engineer proteins with enhanced properties. These custom-designed proteins are intended for applications in the pharmaceutical, chemical, and sustainability sectors, aiming to accelerate the development of commercial products.
Key facts
At-a-glance profile data
- Website
- scala-bio.com
- Headquarters
- Tel Aviv, Israel
- Founded
- 2021
- Employees
- 30
- Total funding
- $22M (Series A)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 31 Mar 2026 | Series A | $16M | - |
| 11 Sept 2023 | Seed | $6M | TLV Partners |
Tech stack
Detected on scala-bio.com, last scanned 2 Sept 2026. Run your own scan
- Analytics
- Google Tag Manager
- Observability
- Sentry
- Support
- HubSpot
- CMS / Builders
- Wix
- Email provider
- Google Workspace
Add first review
Frequently asked
How much funding has Scala Biodesign raised?
Scala Biodesign has raised a total of $22M in funding. The most recent round on record is Series A.
How many employees does Scala Biodesign have?
Scala Biodesign has approximately 30 people on record.